Exploit Technologies Pte Ltd


The marketing and commercialisation arm of A*STAR

Contact Info  |  Feedback  |  Sitemap

 
 

Tech Marketplace

 
 

Bringing R&D from
Lab to Market

 

Science & Engineering

 

Biomedical Science

 View more offers 

  
   
 

How can WE help YOU?

 
 
  
     
 

Latest News and Announcements

 
 
 
Rhapsody Biologics secures exclusive licence from Exploit Technologies to create a unique and versatile Personalised Peptide Vaccine (PPV) platform

Singapore, 2 Mar 2010 -- Rhapsody Biologics (S) Pte Ltd, a Singapore start-up, had on 2 March 2010 licensed from Exploit Technologies a portfolio of technologies that has gone into the creation a versatile Personalised Peptide Vaccine (PPV) platform to predict and optimise peptide vaccines for use at an individual and population level. The portfolio of technologies is developed by Prof Ren Ee Chee at the Singapore Immunology Network (SIgN) of the Singapore Agency for Science, Technology and Research (A*STAR).

 

Read More

 
 
Up-round Investment into D-SIMLAB Technologies Pte Ltd

Singapore, 1 Mar 2010 -- D-SIMLAB Technologies Pte Ltd (“D-SIMLAB”), the Singapore-headquartered leading provider of high-performance, simulation-based decision support solutions, has successfully raised another round of investment from Tan Gee Beng Pte Ltd (TGBPL), a Singapore-based company with interests ranging from manufacturing, trading, property development and investments to high technology industries.

Read More


Start-up licenses high performance network traffic analysis engine from Exploit Technologies


Singapore, 10 Feb 2010 -- 

Niometrics Pte Ltd, a Singapore start-up, had on 5 February 2010 licensed from Exploit Technologies a next-generation, highly accurate traffic recognition engine, developed by the Institute for Infocomm Research (I2R) of the Singapore Agency for Science, Technology and Research (A*STAR). The licensed technology, codenamed as CUB4, is a home-grown, high-performance, software-based traffic analysis engine. As part of its licensing agreement with Exploit Technologies, the strategic marketing and commercialisation arm of A*STAR, Niometrics will further develop and produce a range of new security products and services. 



D-SIMLAB Technologies and EADS Innovation Works Singapore to Sign Memorandum of Understanding in the Field of Spare Parts Management

Singapore, 8 Feb 2010 -- D-SIMLAB Technologies Pte Ltd (“D-SIMLAB”), the Singapore-headquartered leading provider of high-performance, simulation-based decision support solutions, and EADS Innovation Works Singapore, have signed a Memorandum of Understanding (MOU). This MOU paves the way for D-SIMLAB and EADS to undertake and promote joint collaboration activities and projects for the purpose of establishing and advancing new service models and logistics policies for spare parts.